bloc 33rd Square Business Tools - autism 33rd Square Business Tools: autism - All Post
Showing posts with label autism. Show all posts
Showing posts with label autism. Show all posts

Monday, July 27, 2015

Computational Neuroscience Used to Understand Autism

Autism  


Using an artificial neural network, researchers may have helped uncover some of the underlying causes of autism. They propose that alterations in nonlinear, canonical computations occurring throughout the brain may underlie the behavioral characteristics of the condition.
 


Autism diagnoses in recent decades have dramatically increased in prevalence, and people with autism in the United States are now believed to number one in 68. Correspondingly, an increasing number of research efforts seek genetic, epigenetic, neurological and other foundational causes of autism.

Related articles

Autism affects individuals at cognitive, motor, and perceptual levels, and because symptoms vary in degree between individuals, it is conceived as a spectrum disorder. Since it manifests with a heterogeneous set of symptoms, rather than impacting individual neural systems, researchers at Baylor College of Medicine speculated that autism may arise from global differences in neural computation. They've published the results of their study in the Proceedings of the National Academy of Science (PNAS).

"Divisive normalization" is regarded as a canonical computation that occurs throughout the brain. This kind of computation divides the activities of individual neurons by the combined activity of the neuronal population in which they are embedded. It basically controls the ratio of neural excitation to inhibition (E/I), and is implicated in a wide range of functions including sensory encoding and decision making. Hypothetically, E/I is imbalanced in the brains of people with autism.

"These analyses show how a computational framework can provide insights into the neural basis of autism and facilitate the generation of falsifiable hypotheses."


There's a lot of evidence from previous autism research pointing toward this imbalance. Excitatory glutamatergic and inhibitory GABAergic neurons coordinate to create an E/I balance that is essential for normal brain activity. Among other things, the E/I balance is responsible for the critical timing of neurodevelopmental stages and computations in the primary visual cortex. The authors note that experience-dependent neural plasticity is altered in mice lacking GAD, an enzyme that helps to convert glutamate to GABA. The connection is further reinforced by biochemical analyses and the presence of susceptibility gene candidates.

To test the idea, the researchers simulated a population of neurons in the primary visual cortex, and compared this nonlinear neural network's response properties before and after divisive normalization. The framework of altered divisive normalization predicts that autism will broadly affect processes requiring so-called "cognitive marginalization," involved in such functions as social cognition and visual searching, and the researchers observe that reducing the inhibitory function of divisive normalization can account for the perceptual symptoms of autism.

"These analyses show how a computational framework can provide insights into the neural basis of autism and facilitate the generation of falsifiable hypotheses," write the study authors.

The differing expression of divisive normalization across brain regions can account for the phenotypic diversity of autism symptoms between individuals. The authors write, "Qualitative differences between individuals should occur when alterations in divisive normalization have an impact on different brain areas. Quantitative differences should instead reflect the extent to which divisive normalization is affected."

The study strongly implicates the neuronal milieu—the specific regions where neurons are embedded—as a basis of autism. Further, the framework of altered divisive normalization points the way toward further investigations of neural computation and autism symptomology, and the authors note that it may have applications in studies of schizophrenia and aging. "We suggest that computational perspectives can play an important role in the future of mental health research, providing insights that will aid in understanding and treating complex disorders such as autism," they write. 

SOURCE  Extreme Tech


By 33rd SquareEmbed




Thursday, April 30, 2015

New Understanding of Memory Formation in the Brain Found

 Neuroscience  
Researchers have found that the signalling protein Asef2 is a critical regulator of dendritic spines and synapses and memory formation. Asef2 has been found to promote spine and synapse formation by activating another protein called Rac. They also discovered that yet another protein, spinophilin, recruits Asef2 and guides it to specific spines.





Every time you make a memory, somewhere in your brain a tiny filament reaches out from one neuron and forms an electrochemical connection to a neighboring neuron.

Now, a team of biologists at Vanderbilt University, headed by Associate Professor of Biological Sciences Donna Webb, have studied how these connections are formed at the molecular and cellular level.

"Once we figure out the mechanisms involved, then we may be able to find drugs that can restore spine formation in people who have lost it, which could give them back their ability to remember."


The filaments that make these new connections are called dendritic spines and, in a series of experiments published in the Journal of Biological Chemistry, the researchers report that a specific signaling protein, Asef2, a member of a family of proteins that regulate cell migration and adhesion, plays a critical role in spine formation. This is significant because Asef2 has been linked to autism and the co-occurrence of alcohol dependency and depression.

“Alterations in dendritic spines are associated with many neurological and developmental disorders, such as autism, Alzheimer’s disease and Down Syndrome,” said Webb. “However, the formation and maintenance of spines is a very complex process that we are just beginning to understand.”

filapodia
Fluorescent microphotograph of neurons that shows filapodia extending out from dendrite. Image Source: Webb Lab / Vanderbilt)

Neuron cell bodies produce two kinds of long fibers that weave through the brain: dendrites and axons. Axons transmit electrochemical signals from the cell body of one neuron to the dendrites of another neuron. Dendrites receive the incoming signals and carry them to the cell body. This is the way that neurons communicate with each other.

As they wait for incoming signals, dendrites continually produce tiny flexible filaments called filopodia. These poke out from the surface of the dendrite and wave about in the region between the cells searching for axons. At the same time, biologists think that the axons secrete chemicals of an unknown nature that attract the filopodia. When one of the dendritic filaments makes contact with one of the axons, it begins to adhere and to develop into a spine. The axon and spine form the two halves of a synaptic junction. New connections like this form the basis for memory formation and storage.
Related articles

Autism has been associated with immature spines, which do not connect properly with axons to form new synaptic junctions. However, a reduction in spines is characteristic of the early stages of Alzheimer’s disease. This may help explain why individuals with Alzheimer’s have trouble forming new memories.

The formation of spines is driven by actin, a protein that produces microfilaments and is part of the cytoskeleton. Webb and her colleagues showed that Asef2 promotes spine and synapse formation by activating another protein called Rac, which is known to regulate actin activity. They also discovered that yet another protein, spinophilin, recruits Asef2 and guides it to specific spines.

“Once we figure out the mechanisms involved, then we may be able to find drugs that can restore spine formation in people who have lost it, which could give them back their ability to remember,” said Webb.


SOURCE  Vanderbilt University

By 33rd SquareEmbed

Wednesday, March 11, 2015

Genetic Link Found Between Autism and Intelligence

 Autism  
New research suggests genes linked with a greater risk of developing autism may also be associated with higher intelligence.





Genes linked with a greater risk of developing autism may also be associated with higher intelligence, a study suggests.The relationship between autism and intelligence is not clear, researchers say. Although up to 70 per cent of individuals with autism have an intellectual disability, some people with the disorder have relatively well-preserved, or even higher than average, non-verbal intelligence, the team says.

Autism is a developmental disability that can cause significant language and speech difficulties. Non-verbal intelligence enables people to solve complex problems using visual and hands-on reasoning skills requiring little or no use of language.

Related articles
Researchers at the Universities of Edinburgh and Queensland analysed almost 10,000 people recruited from the general population of Scotland. Individuals were tested for general cognitive ability and had their DNA analysed.

The team found that even among people who never develop autism, carrying genetic traits associated with the disorder is, on average, linked to scoring slightly better on cognitive tests. The researchers found further evidence of a link between autism-associated genes and intelligence when they carried out the same tests on 921 adolescents who were part of the Brisbane Adolescent Twin Study.

"Our findings show that genetic variation which increases risk for autism is associated with better cognitive ability in non-autistic individuals."


The study is published in the journal Molecular Psychiatry.

Dr Toni-Kim Clarke, of the University of Edinburgh's Division of Psychiatry, who led the study, said: "Our findings show that genetic variation which increases risk for autism is associated with better cognitive ability in non-autistic individuals. As we begin to understand how genetic variants associated with autism impact brain function, we may begin to further understand the nature of autistic intelligence."

Professor Nick Martin, of the Queensland Institute for Medical Research, said: "Links between autism and better cognitive function have been suspected and are widely implied by the well-known "Silicon Valley syndrome" and films such as Rain Man as well as in popular literature. This study suggests genes for autism may actually confer, on average, a small intellectual advantage in those who carry them, provided they are not affected by autism."


SOURCE  The University of Edinburgh

By 33rd SquareEmbed

Wednesday, January 28, 2015

Autism Speaks Study Finds The Disorder's Genomics More Complex Than Previously Thought

Autism  
The largest-ever autism genome study reveals that the disorder’s genetic underpinnings are even more complex than previously thought. The findings suggest siblings who have autism have different autism-linked genes.






The largest-ever autism genome study reveals that the disorder’s genetic underpinnings are even more complex than previously thought: Most siblings who have autism spectrum disorder (ASD) have different autism-linked genes.

Led by the director of the Autism Speaks MSSNG project (pronounced “missing”), the report made the cover of Nature Medicine.

Simultaneous with publication, the study’s data became part of the historic first upload of approximately 1,000 autism genomes to the Autism Speaks MSSNG portal on the Google Cloud Platform.

Autism Speaks will be making the de-identified data freely available for global research to speed understanding of autism and the development of individualized treatments. The goal of the project’s first phase is to upload 10,000 sequenced autism genomes, together with state-of-the-art, web-based analytic tools.

Related articles
“This is a historic day,” says study leader Stephen Scherer, “as it marks the first time whole genome sequences for autism will be available for research on the MSSNG open-science database. This is an exemplar for a future when open-access genomics will lead to personalized treatments for many developmental and medical disorders.” In addition to leading Autism Speaks’ MSSNG program, Dr. Scherer directs the Centre for Applied Genomics at Toronto’s Hospital for Sick Children and the McLaughlin Centre at the University of Toronto.

"This is an exemplar for a future when open-access genomics will lead to personalized treatments for many developmental and medical disorders."


“By using the cloud to make data like this openly available to researchers around the world, we’re literally breaking down barriers in a way never done before,” says Autism Speaks Chief Science Officer Robert Ring. “As always, our goal at Autism Speaks is to accelerate scientific discovery that will ultimately improve the lives of individuals with autism at home and around the world.” Dr. Ring is among the co-authors of today’s Nature Medicine report.

In its first phase, the MSSNG project aims to make at least 10,000 sequenced autism genomes available for research, along with a "tool box" of state-of-the-art instruments to aide analysis.

In the new study, the researchers sequenced 340 whole genomes from 85 families, each with two children affected by autism. They found that the majority of siblings (69 percent) had little to no overlap in the gene variations known to contribute to autism. Less than a third (31 percent) of the sibling pairs shared the same autism-associated genes.

The findings challenge long-held presumptions. Because autism often runs in families, experts had assumed that siblings with the disorder were inheriting the same autism-predisposing genes from their parents. It now appears this may not be true in most cases.

“We knew that there were many differences in autism, but our recent findings firmly nail that down,” Dr. Scherer says. “We believe that each child with autism is like a snowflake – unique from the other.”

“This means we should not be looking just for suspected autism-risk genes, as is typically done in diagnostic genetic testing,” Dr. Scherer adds. “A full assessment of each individual’s genome is needed to determine how to best use knowledge of genetic factors in personalized autism treatment.” Whole genome sequencing goes far beyond traditional genetic testing to analyze an individual’s complete DNA sequence.



Note - 2016-02-08

Reader Angela Tollersons writes, "Parents of special needs children – and all parents, for that matter – deserve a helping hand from their community, which is why I feel it’s so important that we lend them our support. I believe you and I have a shared goal of spreading information on important health issues."

She suggests the following resources for parents dealing with autism:

Nutrition for ASD Children

http://www.eatright.org/resource/health/diseases-and-conditions/autism/nutrition-for-your-child-with-autism-spectrum-disorder-asd


Coping Mechanisms for Anxiety and ASD

http://www.iidc.indiana.edu/pages/anxiety-and-autism-spectrum-disorders


Why My Son with Autism Needs Routine (With Video)

https://www.autismspeaks.org/blog/2014/09/16/moment-i-got-my-son-autisms-need-routine


The Well Travel Guide for Parents of Autism Spectrum Children

https://travelblog.expedia.ca/autism-travel-guide/



Let’s Have Fun: Activities for Children with Autism

http://www.education.com/magazine/article/10-activities-children-autism/



SOURCE  Autism Speaks


By 33rd SquareEmbed

Monday, January 26, 2015

Neuroscientists Begin To Crack the Brain's Genetic Code
 Neuroscience  
Scientists are linking genetics and connectomics big data to target the conditions affecting various neurological conditions like Alzheimer's disease, depression and autism.  The ENIGMA project has released their recent findings.




The largest collaborative study of the brain to date has announced results. Researchers from the Keck School of Medicine of the University of Southern California (USC) led a global consortium of 190 institutions to identify eight common genetic mutations that appear to age the brain an average of three years. The discovery could lead to targeted therapies and interventions for Alzheimer’s disease, autism and other neurological conditions.

An international team of roughly 300 scientists known as the Enhancing Neuro Imaging Genetics through Meta Analysis (ENIGMA) Network pooled brain scans and genetic data worldwide to pinpoint genes that enhance or break down key brain regions in people from 33 countries. This is the first high-profile study since the National Institutes of Health (NIH) launched its Big Data to Knowledge (BD2K) centers of excellence in 2014.

"ENIGMA’s scientists screen brain scans and genomes worldwide for factors that help or harm the brain — this crowd-sourcing and sheer wealth of data gives us the power to crack the brain’s genetic code."


The research was published in the journal Nature.

“ENIGMA’s scientists screen brain scans and genomes worldwide for factors that help or harm the brain — this crowd-sourcing and sheer wealth of data gives us the power to crack the brain’s genetic code,” said Paul Thompson, Ph.D., Keck School of Medicine of USC professor and principal investigator of ENIGMA.

“Our global team discovered eight genes that may erode or boost brain tissue in people worldwide. Any change in those genes appears to alter your mental bank account or brain reserve by 2 or 3 percent. The discovery will guide research into more personalized medical treatments for Alzheimer’s, autism, depression and other disorders.”

The study could help identify people who would most benefit from new drugs designed to save brain cells, but more research is necessary to determine if the genetic mutations are implicated in disease.

Autism Brain Development
Adolescents with autism showed an altered pattern of brain development. Image Source -  USC Imaging Genetics Center
Related articles
The ENIGMA researchers screened millions of “spelling differences” in the genetic code to see which ones affected the size of key parts of the brain in magnetic resonance images (MRIs) from 30,717 individuals. The MRI analysis focused on genetic data from seven regions of the brain that coordinate movement, learning, memory and motivation.

"We found that healthy individuals who carry a gene variation linked to an increased risk of autism have structural differences in their brains that may help explain how the gene affects brain function and increases vulnerability for autism," the team writes on the USC Imaging Genetics Center website, for instance.

The group identified eight genetic variants associated with decreased brain volume, several found in over one-fifth of the world’s population.  People who carry one of those eight mutations had, on average, smaller brain regions than brains without a mutation but of comparable age; some of the genes are implicated in cancer and mental illness.

Recently, the NIH invested nearly $32 million in its Big Data Initiative, creating 12 research hubs across the United States to improve the utility of biomedical data. USC’s two BD2K centers of excellence, including ENIGMA, were awarded a total of $23 million over four years.

“The ENIGMA Center’s work uses vast datasets as engines of biomedical discovery; it shows how each individual’s genetic blueprint shapes the human brain,” said Philip Bourne, Ph.D., associate director for data science at the NIH. “This ‘Big Data’ alliance shows what the NIH Big Data to Knowledge (BD2K) Program envisions achieving with our 12 Centers of Excellence for Big Data Computing.”


SOURCE  USC

By 33rd SquareEmbed

Wednesday, January 21, 2015

'Idiosyncratic' Brain Patterns in Autism Discovered

 Neuroscience  
New research suggests that the various reports—of both over-and under-connectivity—may, in fact, reflect a deeper principle of brain function. The study shows that the brains of individuals with autism display unique synchronization patterns, something that could impact earlier diagnosis of the disorder and future treatments.




New research recently published in Nature Neuroscience suggests that the various reports—of both over-and under-connectivity—may, in fact, reflect a deeper principle of brain function. Led by scientists at the Weizmann Institute and Carnegie Mellon University, the study shows that the brains of individuals with autism display unique synchronization patterns, something that could impact earlier diagnosis of the disorder and future treatments.

"Identifying brain profiles that differ from the pattern observed in typically developing individuals is crucial not only in that it allows researchers to begin to understand the differences that arise in ASD but, in this case, it opens up the possibility that there are many altered brain profiles all of which fall under the umbrella of 'autism' or 'autisms,'" said Marlene Behrmann, the George A. and Helen Dunham Cowan Professor of Cognitive Neuroscience at Carnegie Mellon and co-director of the Center for the Neural Basis of Cognition.

"Identifying brain profiles that differ from the pattern observed in typically developing individuals is crucial not only in that it allows researchers to begin to understand the differences that arise in ASD."


To investigate the issue of connectivity in ASD, the researchers analyzed data obtained from functional magnetic resonance imaging (fMRI) studies conducted while the participants were at rest. Data was collected from a large number of participants at multiple sites and handily assembled in the ABIDE database.

"Resting-state brain studies are important because that is when patterns emerge spontaneously, allowing us to see how various brain areas naturally connect and synchronize their activity," said Avital Hahamy, a Ph.D. student in Weizmann's Neurobiology Department.

Related articles
A number of previous studies by these researchers and others suggest that these spontaneous patterns may provide a window into individual behavioral traits, including those that stray from the norm.
In a careful comparison of the details of these intricate synchronization patterns, the scientists discovered an intriguing difference between the control and ASD groups: the control participants' brains had substantially similar connectivity profiles across different individuals, while those with ASD showed a remarkably different phenomenon. Those with autism tended to display much more unique patterns—each in its own, individual way. They realized that the synchronization patterns seen in the control group were "conformist" relative to those in the ASD group, which they termed "idiosyncratic."

Differences between the synchronization patterns in the autism and control groups could be explained by the way individuals in the two groups interact and communicate with their environment.

"From a young age, the average, typical person's brain networks get molded by intensive interaction with people and the mutual environmental factors," Hahamy said. "Such shared experiences could tend to make the synchronization patterns in the control group's resting brains more similar to each other. It is possible that in ASD, as interactions with the environment are disrupted, each one develops a more uniquely individualistic brain organization pattern."

The researchers emphasize that this explanation is only tentative; much more research will be needed to fully uncover the range of factors that may lead to ASD-related idiosyncrasies. They also suggest that further research into how and when different individuals establish particular brain patterns could help in the future development of early diagnosis and treatment for autism disorders.


SOURCE  Carnegie Mellon University via EurekAlert

By 33rd SquareEmbed

Tuesday, January 13, 2015

Genetic Determinants of Autism and Cancer Found Using Deep Learning

 Genomics  
Researchers have developed a computational system that mimics the biology of RNA splicing by correlating DNA elements with splicing levels in healthy human tissues. The system can scan DNA and identify damaging genetic variants. This procedure has led to insights into the genetics of autism, cancers, and spinal muscular atrophy.




Scientists and engineers have built a computer model that has uncovered disease-causing mutations in large regions of the genome that previously could not be explored. Their method seeks out mutations that cause changes in ‘gene splicing,’ and has revealed unexpected genetic determinants of autism, colon cancer and spinal muscular atrophy.

Canadian Institute For Advanced Research (CIFAR) senior fellow Brendan Frey, also a professor at the University of Toronto’s Donnelly Centre for Cellular & Biomolecular Research, is the lead author on a paper describing this work, which appeared in the journal of Science Express.

"This work promises to interpret the impact of mutations in a broader region of our genome than has been previously possible."


The paper was co-authored by CIFAR senior fellows Timothy Hughes (University of Toronto) and Stephen Scherer (the Hospital for Sick Children and the University of Toronto) of the Genetic Networks program. Frey is appointed to the Genetic Networks program, and the Neural Computation & Adaptive Perception program.

The research combines the latter groups’ pioneering work on deep learning with novel techniques in genetics.

Most existing methods examine mutations in segments of DNA that encode protein, which Frey refers to as low-hanging fruit. To find mutations outside of those segments, typical approaches such as genome-wide association studies take disease data and compare the mutations of sick patients to those of healthy patients, seeking out patterns. Frey compares the approach to lining up all the books your child likes to read and looking for whether a particular letter occurs more frequently than in other books.

“It doesn’t work, because it doesn’t tell you why your kid likes the book,” he says. “Similarly, genome-wide association studies can’t tell you why a mutation is problematic.”

But looking at splicing can do that. Splicing is important for the vast majority of genes in the human body. When mutations alter splicing, genes may produce no protein, the wrong one or some other problem, which could lead to disease.

Related articles
Frey’s team, which includes researchers from engineering, biology and medicine, developed a computer model that mimics how the cell directs splicing by detecting patterns within DNA sequences, called the ‘splicing code’. The researchers then used their system to examine mutated DNA sequences and determine what effects the mutations would have, effectively scoring each mutation. Unlike existing methods, their technique provides an explanation for the effect of a mutation and can be used to find mutations outside of segments that code for protein.

To develop the computer model, Frey’s team fed experimental data into machine learning algorithms, in order to teach the computer how to examine a DNA sequence and output the splicing pattern.

Their method worked surprisingly well and has led to new discoveries. For example, using DNA sequences from five patients with autism provided by Scherer, the model was able to identify 39 new genes that could be implicated in autism spectrum disorder, a significant increase from about 100 previously known autism genes.

“Brendan's work is groundbreaking because it represents a first serious attempt to decode the portions of that 98 percent of the human genome outside the genes that are typically studied in genetic disease studies,” says Scherer. “This is particularly exciting since it is thought these segments of DNA may contain much of the missing information that we have been looking for in studies like autism.”

The research also sheds light on the genetic mechanisms that lead to spinal muscular atrophy, a leading cause of infant death, and nonpolyposis colorectal cancer.

"Many of us will soon know our complete human genome sequence, which will be like having an encyclopedic guide to ourselves that is written in an alien language,” says Frederick Roth, CIFAR senior fellow and co-director of the program in Genetic Networks. “This work promises to interpret the impact of mutations in a broader region of our genome than has been previously possible.”

SOURCE  Lab Canada Top Image - Frey Lab

By 33rd SquareEmbed

Thursday, December 4, 2014

Researchers Looking at "Chemo Brain" Find Possible Link to Autism

 Medicine  
It has been found that the common chemotherapy drug topotecan disrupts a gene integral for neuron communication, though the effects are reversible. The research also homes in on an underlying cause of autism.




Researchers have found for the first time a biochemical mechanism that could be a cause of “chemo brain” – the neurological side effects such as memory loss, confusion, difficulty thinking, and trouble concentrating that many cancer patients experience while on chemotherapy to treat tumors in other parts of the body

The research, published in the Proceedings of the National Academy of Sciences (PNAS), shows how the common chemotherapy drug topotecan can drastically suppress the expression of Topoisomerase-1, a gene that triggers the creation of proteins essential for normal brain function.

Specifically, the drug tamps down the proteins that are necessary for neurons to communicate through synapses. However, the researchers found that the protein levels and synaptic communication return to normal when the drug is removed.

Related articles
“There’s still a question in the cancer field about the degree to which some chemotherapies get into the brain,” said Mark Zylka, PhD, associate professor of cell biology and physiology and co-senior author of the PNAS paper. “But in our experiments, we show that if they do get in, they can have a dramatic effect on synaptic function. We think drug developers should be aware of this when testing their next generation of topoisomerase inhibitors.”

The researchers also suggest that if these synaptic enzymes are affected during brain development and throughout life, then the result could be long-term neurodevelopmental problems, such as those found in people with Autism Spectrum Disorder. Essentially, the brain would be wired incorrectly. Topotecan is not the only “environmental factor” that can suppress the genes linked to autism. Research to quantify these biochemical effects in animals is ongoing.

"Many in the cancer field are focused, as they should be, on whether a drug can kill a tumor, not what the cognitive side effects might be."


The PNAS study comes one year after Zylka and UNC colleague Ben Philpot, PhD, professor of cell biology and physiology, reported in Nature that topotecan halted the expression of unusually long genes in neurons – the same synaptic genes linked to autism. This discovery led them to investigate how topotecan affects the specific topoisomerase enzymes in cancer cells and in neurons.

“The cells seemed quiet, as if in a dormant state,” NC postdoctoral fellow Angela Mabb, PhD said. “But they remained healthy. And once the drug was washed out, the synaptic function returned to normal.”

These experiments used only topotecan, but there’s an entire class of topoisomerase inhibitors. Many other similar drugs are now in development and scientists have already found that these drugs can effectively penetrate the blood-brain barrier.

“Many in the cancer field are focused, as they should be, on whether a drug can kill a tumor, not what the cognitive side effects might be,” Zylka said. “But this study provides insights into potential serious side effects of drugs used to treat various forms of cancer. It is very good to know that at UNC we have a big effort to study patient-reported outcomes during therapy so that we can balance care for the whole person.”


SOURCE  University of North Carolina

By 33rd SquareEmbed

Monday, November 17, 2014

Fragile X Related Protein 1

 Neuroscience  
A new study has identified new player in brain function and memory. When the scientists removed a molecule from the brains of mice, they found memory-creation molecules flourished. 




R esearchers have identified a molecule that regulates brain processing and found that when it is removed, brain function and memory recall is improved.

The study was published in the latest issue of Cell Reports, and has implications for neurodevelopmental and neurodegenerative diseases, such as autism spectral disorders and Alzheimer’s disease.

Related articles
“Previous research has shown that production of new molecules is necessary for storing memories in the brain; if you block the production of these molecules, new memory formation does not take place,” says RI-MUHC neuroscientist, Dr. Keith Murai, the study’s senior author and Associate Professor in the Department of Neurology and Neurosurgery at McGill University. “Our findings show that the brain has a key protein that limits the production of molecules necessary for memory formation. When this brake-protein is suppressed, the brain is able to store more information.”

"Our findings show that the brain has a key protein that limits the production of molecules necessary for memory formation. When this brake-protein is suppressed, the brain is able to store more information."


Murai and his colleagues used a mouse model to study how changes in brain cell connections produce new memories.  They showed that a protein, FXR1P (Fragile X Related Protein 1), was responsible for suppressing the production of molecules required for building new memories.

When FXR1P was removed from certain parts of the brain, new molecules were produced that strengthened connections between brain cells and this correlated with improved memory and recall in the mice.

“The role of FXR1P was a surprising result,” says Dr. Murai. “Previous to our work, no-one had identified a role for this regulator in the brain. Our findings have provided fundamental knowledge about how the brain processes information. We’ve identified a new pathway that directly regulates how information is handled and this could have relevance for understanding and treating brain diseases.”

“Future research in this area could be very interesting,” he adds. “If we can identify compounds that control the braking potential of FXR1P, we may be able to alter the amount of brain activity or plasticity. For example, in autism, one may want to decrease certain brain activity and in Alzheimer’s disease, we may want to enhance the activity."

 Apart from the benefits to medicine research like this may, one day extend basic human capabilities.  Murai says, "By manipulating FXR1P, we may eventually be able to adjust memory formation and retrieval, thus improving the quality of life of people suffering from brain diseases.”


SOURCE  McGill University

By 33rd SquareEmbed

Tuesday, October 14, 2014

Mental Health Technology - What the Future Holds

 Medicine  
Technology is changing how people view and treat mental health disorders. With new sensors and data management tools, Silicon Valley is changing the face of mental health diagnostics.




D
iagnosing mental health disorders used to be gut-level. Clinicians shoveled deep into the minds of patients, and then filtered the responses through the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM). The accuracy of diagnoses was often proportional to the experience of the clinician, so pay for the best!

"Just as software bugs are often the cause of our computer problems, our mental motherboards can be done in by our psychological processing."


Now, Silicon Valley is changing the face of mental health diagnostics. Complex disorders are being reduced, diagnosed and treated as chemical imbalances and mechanical maladjustments. Kirsten Weir, writing for the June 2012 Monitor of Psychology, says, “Just as software bugs are often the cause of our computer problems, our mental motherboards can be done in by our psychological processing.” More and more, technology is changing how people view and treat mental health disorders.

Related articles

Skin Conductance Wristbands – Autism, Depression

The human wrist is a synopsis of the body’s internal cogworks. Wristband monitors can check heart rate, body temperature, macro-movement and skin conductance, sort of like mood rings. Researchers at the Massachusetts Institute of Technology wound wristbands on autistic children and discovered that a child’s outer actions may not accurately reflect his internal state. Scientists hope that these wristbands, or even sensor-equipped smartphones, will help explain autistic behavior, identify depression triggers, and report anxiety attacks.

Brain Positron Emission Tomography (PET) – Alzheimer’s, Schizophrenia

The PET process is simple: A glucose doppelganger, called a radiotracer, is injected into the bloodstream. As it travels, it emits positrons, like the beeps of a pager, which are picked up by a computer. The computer generates a 2D image of neurological metabolic activity. Currently, PET is used to diagnose and distinguish between Alzheimer’s disease and other forms of dementia. Physicians hope that PET will one day explore changes in neural activity in patients afflicted by schizophrenia.

Self-Learning MRI Database – Behavioral Development

During 2001 through 2007, the National Institute of Health (NIH) collected MRI data on more than 500 children at physiological milestones in their lives. The NIH released the data goldmine to qualified pediatricians under the simple idea: If physicians can see a good brain, they can recognize a bad brain. Judith Ramsey of the National Institute of Mental Health says, “Differences between boys and girls and relationships to cognitive and behavioral development can be used to understand individual differences or normal variability.”

Our mental health is becoming a hot button issue with the emergency of understanding of the human mind. The age of the pen and paper questionnaire is passing. Mental health will be much less mental; intuition will be replaced by sensors, ECUs – and maybe even wristbands. Progression in science and technology will help us unlock the secrets of the mind and with help from these sources we can have a better understanding of what our minds can do.

Information Credit: Mindset Consulting Group

By Meghan BelnapEmbed

Friday, August 22, 2014

Children with Autism Found to Have Extra Synapses in Brain

 Autism  
A new study suggests that in children with autism, something in the process goes awry, leaving an oversupply of synapses in at least some parts of the brain. The study is an important step forward in understanding what’s happening in the brains of people with autism.




A utism was recently speculated to be a possible sign of the next stage of human evolution by Juan Enriquez.  Now, children and adolescents with autism have been found to have a surplus of synapses in the brain, and this excess is due to a slowdown in a normal brain “pruning” process during development.  The study ws conducted by neuroscientists at Columbia University Medical Center (CUMC).

The reseach was published in the online issue of the journal Neuron.

Synapses are the points where neurons connect and communicate with each other, so the researchers speculate the excessive synapses may have profound effects on how the brain functions.

A drug that restores normal synaptic pruning can improve autistic-like behaviors in mice, the researchers found, even when the drug is given after the behaviors have appeared.

"The goal now is to understand how those hundreds of genes cluster together into a smaller number of pathways; that will give us better clues to potential treatments."


Although the drug, rapamycin, has side effects that may preclude its use in people with autism, “the fact that we can see changes in behavior suggests that autism may still be treatable after a child is diagnosed, if we can find a better drug,” said the study’s senior investigator, David Sulzer, PhD, professor of neurobiology in the Departments of Psychiatry, Neurology, and Pharmacology at CUMC.

extra synapses in autism
Neurons in brains from people with autism do not undergo normal pruning during childhood and adolescence. The images show representative neurons from unaffected brains (left) and brains from autistic patients (right); the spines on the neurons indicate the location of synapses. Image Source: Guomei Tang, PhD and Mark S. Sonders, PhD/Columbia University Medical Center
During normal brain development, a burst of synapse formation occurs in infancy, particularly in the cortex, a region involved in autistic behaviors; pruning eliminates about half of these cortical synapses by late adolescence. Synapses are known to be affected by many genes linked to autism, and some researchers have hypothesized that people with autism may have more synapses.

Neurons in brains from people with autism do not undergo normal pruning during childhood and adolescence. The images show representative neurons from unaffected brains (left) and brains from autistic patients (right); the spines on the neurons indicate the location of synapses. (Image credit: Guomei Tang, PhD and Mark S. Sonders, PhD/Columbia University Medical Center)

To test this hypothesis, co-author Guomei Tang, PhD, assistant professor of neurology at CUMC, examined brains from children with autism who had died from other causes. Thirteen brains came from children ages two to 9, and thirteen brains came from children ages 13 to 20. Twenty-two brains from children without autism were also examined for comparison.

Dr. Tang measured synapse density in a small section of tissue in each brain by counting the number of tiny spines that branch from these cortical neurons; each spine connects with another neuron via a synapse.

By late childhood, she found, spine density had dropped by about half in the control brains, but by only 16 percent in the brains from autism patients.

“It’s the first time that anyone has looked for, and seen, a lack of pruning during development of children with autism,” Dr. Sulzer said, “although lower numbers of synapses in some brain areas have been detected in brains from older patients and in mice with autistic-like behaviors.”

Clues to what caused the pruning defect were also found in the patients’ brains; the autistic children’s brain cells were filled with old and damaged parts and were very deficient in a degradation pathway known as “autophagy.” Cells use autophagy (a term from the Greek for self-eating) to degrade their own components.

A "self-eating" impairment in the neurons of autism patients is shown with the decrease of an autophagy marker (red color) compared to unaffected neurons. Image: Guomei Tang/CUMC.

Related articles
Using mouse models of autism, the researchers traced the pruning defect to a protein called mTOR. When mTOR is overactive, they found, brain cells lose much of their “self-eating” ability. And without this ability, the brains of the mice were pruned poorly and contained excess synapses. “While people usually think of learning as requiring formation of new synapses, “Dr. Sulzer says, “the removal of inappropriate synapses may be just as important.”

The researchers could restore normal autophagy and synaptic pruning—and reverse autistic-like behaviors in the mice—by administering rapamycin, a drug that inhibits mTOR. The drug was effective even when administered to the mice after they developed the behaviors, suggesting that such an approach may be used to treat patients even after the disorder has been diagnosed.

Because large amounts of overactive mTOR were also found in almost all of the brains of the autism patients, the same processes may occur in children with autism.

“What’s remarkable about the findings,” said Dr. Sulzer, “is that hundreds of genes have been linked to autism, but almost all of our human subjects had overactive mTOR and decreased autophagy, and all appear to have a lack of normal synaptic pruning. This says that many, perhaps the majority, of genes may converge onto this mTOR/autophagy pathway, the same way that many tributaries all lead into the Mississippi River. Overactive mTOR and reduced autophagy, by blocking normal synaptic pruning that may underlie learning appropriate behavior, may be a unifying feature of autism.”

Alan Packer, PhD, senior scientist at the Simons Foundation, which funded the research, said the study is an important step forward in understanding what’s happening in the brains of people with autism.

“The current view is that autism is heterogeneous, with potentially hundreds of genes that can contribute. That’s a very wide spectrum, so the goal now is to understand how those hundreds of genes cluster together into a smaller number of pathways; that will give us better clues to potential treatments,” he said.

“The mTOR pathway certainly looks like one of these pathways. It is possible that screening for mTOR and autophagic activity will provide a means to diagnose some features of autism, and normalizing these pathways might help to treat synaptic dysfunction and treat the disease.”




SOURCE  Columbia University Medical Center

By 33rd SquareEmbed